Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

NCT00917384

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations: ImClone Investigational Site Bakersfield, California, United States

ImClone Investigational Site La Jolla, California, United States

ImClone Investigational Site Redlands, California, United States

ImClone Investigational Site Chicago, Illinois, United States

View all 161 locations

View Trial Details

Completed

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

NCT01170663

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: ImClone Investigational Site Burbank, California, United States

ImClone Investigational Site Los Angeles, California, United States

ImClone Investigational Site San Francisco, California, United States

ImClone Investigational Site Jacksonville, Florida, United States

View all 167 locations

View Trial Details

Completed

A Study of Ramucirumab or Icrucumab in Colorectal Cancer

NCT01111604

Conditions: Adenocarcinoma, Carcinoma, Colon Cancer, +16 more
Locations: ImClone Investigational Site Cincinnati, Ohio, United States

ImClone Investigational Site Columbia, South Carolina, United States

ImClone Investigational Site Nashville, Tennessee, United States

ImClone Investigational Site Calgary, Alberta, Canada

View all 17 locations

View Trial Details

Completed

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

NCT01433172

Conditions: Adenocarcinoma, Carcinoma, Lung Cancer, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma

NCT01339975

Conditions: Adenocarcinoma, Carcinoma, Carcinoma Renal Cell, +15 more
Locations: University Bordeaux Hospital Bordeaux, France

View Trial Details

Completed

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer

NCT01837329

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)

NCT01929616

Conditions: Adenocarcinoma, Advanced Chemorefractory Colorectal Adenocarcinoma, Carcinoma, +3 more
Locations: UZA Antwerp, Edegem, Belgium

Jules Bordet Institute Brussels, Belgium

Hopital Erasme Brussels, Belgium

Cliniques Universitaires Saint Luc Brussels, Belgium

View all 17 locations

View Trial Details

Completed

Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma

NCT03988959

Conditions: Adenocarcinoma, Adenocarcinoma; Mucoepidermoid Carcinoma, Carcinoma, +12 more
Locations: Ain shams university Cairo, Egypt

View Trial Details

Completed

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

NCT00497224

Conditions: Adenocarcinoma, Cancer, Carcinoma, +11 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

British Columbia Cancer Agency Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View Trial Details

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma

NCT01962532

Conditions: Adenocarcinoma, Carcinoma, Esophagogastric Junction, +9 more
Locations: Kashiwa, Japan

Matsuyama, Japan

Tokyo, Japan

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions